Murphy Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,282
Closed -$200K 230
2021
Q2
$200K Buy
+1,282
New +$208K 0.02% 227
2020
Q3
Sell
-1,931
Closed -$223K 205
2020
Q2
$223K Buy
+1,931
New +$223K 0.04% 186
2018
Q4
Sell
-1,926
Closed -$245K 264
2018
Q3
$245K Buy
+1,926
New +$229K 0.03% 238
2018
Q1
Sell
-1,859
Closed -$217K 277
2017
Q4
$217K Hold
1,859
0.03% 254
2017
Q3
$211K Sell
1,859
-289
-13% -$33.4K 0.03% 258
2017
Q2
$267K Hold
2,148
0.04% 230
2017
Q1
$254K Sell
2,148
-51
-2% -$5.78K 0.04% 244
2016
Q4
$220K Sell
2,199
-597
-21% -$64K 0.03% 259
2016
Q3
$353K Buy
2,796
+612
+28% +$75.6K 0.05% 214
2016
Q2
$255K Buy
+2,184
New +$247K 0.04% 254

Other funds holding ZBH

Murphy Capital Management's ZBH Position: Q3 2021 in Review

Murphy Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 1,282 shares — an estimated $200K sold.

Murphy Capital Management first reported a position in ZBH in Q2 2016 and held it in 10 quarters. The position peaked at $353K in Q3 2016. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • Murphy Capital Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • Murphy Capital Management sold 1,282 Zimmer Biomet shares in Q3 2021, an estimated $200K.
  • Murphy Capital Management first reported a position in Zimmer Biomet in Q2 2016 and held it in 10 quarters.
  • Murphy Capital Management's Zimmer Biomet position peaked at $353K in Q3 2016.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Murphy Capital Management's 13F filing for Q3 2021, filed 22 Oct 2021.